Evidence map›Paper›PMID 39614883›Full record

ArticleBioprocess and biosystems engineering2025

Enhanced physicochemical characteristics and biological activities of low-temperature ethylenediamine/urea pretreated lignin.

Yongkang Pan, Weiwei Chen, Qiaozhen Kang, Limin Hao, Jike Lu, Jiaqing Zhu

Abstract read
PubMed Publisher
In one paragraph

Article in Bioprocess and biosystems engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yongkang Pan *School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Weiwei Chen *School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Qiaozhen KangSchool of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Limin HaoSystems Engineering Institute, Academy of Military Sciences (AMS), Beijing, 100010, China.
Jike LuSchool of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China. ljk002004@163.com.
Jiaqing ZhuSchool of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China. zjq0519qing@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-temperature ethylenediamine (EDA)/urea pretreatment had been demonstrated to be an efficient pretreatment method for enzymatic hydrolysis and bioethanol production. For high-value utilization of the third main components of lignocellulosic biomass, the physicochemical structure characteristics and biological activities of low-temperature EDA/urea pretreated lignin (EUL) were comprehensively investigated in the present study. The results demonstrated that the pretreatment process facilitated the depolymerization of lignin, resulting in notable reduction in molecular weight and polydispersity index from 2.32 to 1.42 kg/mol and 1.44 to 1.20, respectively. The EDA/urea pretreated lignin (EUL) exhibited enhanced ultraviolet absorption capacity and the most significant DPPH radical scavenging and inhibition of Staphylococcus aureus in comparison to the primary lignin (PL) and the NaOH pretreated lignin (NL). Enhanced physicochemical characteristics and biological activities of EUL make it more suitable to be developed as sunscreen ingredient or antioxidant and antimicrobial agent in food preservation and conservation.

Indexed as

EthylenediaminesLigninUreaAnti-Bacterial AgentsAntioxidantsStaphylococcus aureusAnti-Bacterial AgentsAntioxidantsethylenediamineEthylenediaminesLigninUreaBiological activitiesLignin valorizationLow-temperature EDA/urea pretreatmentPhysical and chemical properties

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.